| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.12 | 0.007 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.1 | 0.03 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.08 | 0.2 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.066 | 0.2 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.065 | 0.2 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.061 | 0.2 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.061 | 0.2 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.052 | 0.3 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.042 | 0.4 |